Bioactive Compounds Extracted from Mangrove Plants (Avicennia marina and Rhizophora mucronata): an Overview

Publication date: Available online 14 September 2018Source: PathophysiologyAuthor(s): Obidallah Aljaghthmi, Hassaan Heba, Isam Abu ZeidAbstractMangrove plants areeconomically and ecologically important, and have many benefits. They are considered as a nursery ground for many of economically important fishes and shellfishes. There are about 84 mangrove plant species. Two common species of the mangrove plants have featured in traditional medicine for generations, especially in south-east Asia, namely Avicennia marina (A. marina) and Rhizophora mucronata (R. mucronata). Though the pharmacological abilities of the two medicinal plants are unquestioned, they have not yet featured in conventional medicine. The superior activity of the bioactive compounds including alkaloids, flavonoids, phenols, saponins, tannins and terpenoidsin the two plants, derives from the inherent resilience of the trees, which grow in hostile ecological zones, however, that the bioactive compounds of A. marina and R. mucronata have the biggest impact. This makes them evolve strong immunity mechanisms and in diabetes control that they transfer into alkaloids, flavonoids andtannins. This review will guide through the constitution of bioactive compounds, in these two mangrove species, and the treatment possibilities over certain diseases.
Source: Pathophysiology - Category: Pathology Source Type: research